Tonix Pharmaceuticals Holding Corp (TNXP)

Tonix Pharmaceuticals Holding Corp (TNXP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $93.1M; returns 1 day +0.8%, 1 week -14.4%, 1 year -72.2%.

Tonix Pharmaceuticals Holding Corp. is a fully integrated commercial biotechnology company focused on developing and commercializing therapeutics for central nervous system (CNS) disorders, immunology, rare diseases, and infectious diseases.

Groups TNXP belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• Pharmaceuticals
• Commercial Stage
• CNS Disorders
• Pain Management
• Immunotherapy
• Rare Diseases
• Infectious Diseases

TNXP financial model: income statement, cash flow and balance sheet